| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |